Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Total Current Liabilities (2016 - 2025)

Ocular Therapeutix has reported Total Current Liabilities over the past 13 years, most recently at $50.8 million for Q4 2025.

  • Quarterly results put Total Current Liabilities at $50.8 million for Q4 2025, up 22.86% from a year ago — trailing twelve months through Dec 2025 was $50.8 million (up 22.86% YoY), and the annual figure for FY2025 was $50.8 million, up 22.86%.
  • Total Current Liabilities for Q4 2025 was $50.8 million at Ocular Therapeutix, up from $49.3 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for OCUL hit a ceiling of $50.8 million in Q4 2025 and a floor of $21.6 million in Q2 2021.
  • Median Total Current Liabilities over the past 5 years was $30.7 million (2022), compared with a mean of $32.8 million.
  • Biggest five-year swings in Total Current Liabilities: soared 146.91% in 2021 and later decreased 18.23% in 2024.
  • Ocular Therapeutix's Total Current Liabilities stood at $26.3 million in 2021, then grew by 19.2% to $31.4 million in 2022, then grew by 11.15% to $34.9 million in 2023, then increased by 18.51% to $41.4 million in 2024, then increased by 22.86% to $50.8 million in 2025.
  • The last three reported values for Total Current Liabilities were $50.8 million (Q4 2025), $49.3 million (Q3 2025), and $42.9 million (Q2 2025) per Business Quant data.